Showing 2321-2330 of 3361 results for "".
Dr. Garden Discusses Experience with the VariLite Laser
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/dr-garden-discusses-experience-with-gemini-laser/19467/"The VariLite system is a wonderful choice for those people who want to enter into the laser arena. Because many, many patients have vessels which naturally occur as they grow older or especially those who develop rosacea later in life, this is something that many practices have the need for treatDermWireTV: Arcutis Survey on PsO Impact; Tinted Sunscreen Update; Cosmetic Interventions and Illness; Dr. Seemal Desai Elected
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-arcutis-survey-on-pso-impact-tinted-sunscreen-update-cosmetic-interventions-and-illness-dr-seema-desai-elected/20089/Arcutis Biotherapeutics' survey finds Individuals with psoriasis who use topical treatments want more effective and simpler interventions. Intertriginous disease poses particular challenges. Increased availability of tinted sunscreens could increase the use of SPF among individuals with darker skinDermWireTV: GlobalSkin, ILDS Collab; New approach with Tafinlar; Equity in Telehealth; Dupixent pen
https://practicaldermatology.com/topics/practice-management/dermwiretv-globalskin-ilds-collab-new-approach-with-tafinlar-equity-in-telehealth-dupixent-pen/19952/A data analysis presented at the 2021 American Society of Clinical Oncology Annual Meeting shows that a new approach to managing fevers associated with dabrafenib increases treatment tolerability and avoids discontinuation of therapy. Global Skin (International Alliance of Dermatology Patient OrganiRhatigan to Merz, MOC Dissatisfaction, Syneron-Candela Sale
https://practicaldermatology.com/videos/dermwire-tv/dermwiretv-rhatigan-to-merz-moc-dissatisfaction-syneron-candela-sale/18485/Industry veteran Bob Rhatigan is the new President and Chief Executive Officer of Merz North America. Patrick Urban is new Chief Commercial Officer. In a transaction valued at approximately $397 million, an affiliate of funds advised by Apax Partners will acquire all of the outstanding shares of SyStaphylococcus aureus Accessory Gene Regulator Quorum-sensing System Inhibits Keratinocyte Lipid Enzymes and Delays Wound Repair
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/staphylococcus-aureus-accessory-gene-regulator-quorum-sensing-system-inhibits-keratinocyte-lipid-enzymes-and-delays-wound-repair/67354/Therapies aimed at inhibiting agr quorum sensing could be a novel strategy to improve healing outcomes.An Update on the Use of Trifarotene for the Treatment of Acne
https://practicaldermatology.com/columns/clinical-focus-1/an-update-on-the-use-of-trifarotene-for-the-treatment-of-acne/23267/Trifarotene is the first novel topical retinoid approved for the treatment of facial and truncal acne in 20 years.2022 in Review
https://practicaldermatology.com/topics/other-dermatology/2022-in-review/23833/The past year brought many new approvals and advances to dermatology for improved patient care.Preparing for the Future of Teledermatology
https://practicaldermatology.com/issues/supplements/preparing-for-the-future-of-teledermatology/23475/Telehealth served as an important stopgap for medical providers and their patients in the context of the COVID-19 pandemic, but will it persist? And if so, how can you derive the most benefit?Recent Developments
https://practicaldermatology.com/columns/recent-developments/recent-developments-38/23774/MOC Sparks Anger, Frustration in Physician Community
https://practicaldermatology.com/topics/practice-management/moc-sparks-anger-frustration-in-physician-community/20898/Anti-MOC advocates wonder why they cannot get a seat at the table to discuss changing the system.